`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`v.
`
`ICOS CORPORATION,
`Patent Owner
`
`U.S. Patent No. 6,943,166 B1
`Inter Partes Review No. IPR2017-01762
`
`PETITIONER’S REQUEST FOR REFUND
`OF INSTITUTION FEE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The petitioner Argentum Pharmaceuticals LLC (“Argentum”) requests a
`
`refund of the $14,000 institution fee paid when the inter partes review petition was
`
`filed in IPR2017-01762 on July 12, 2017. Pursuant to 35 U.S.C. § 317(b) and 37
`
`C.F.R. § 42.74(c), Petitioner and Patent Owner jointly requested termination on
`
`August 28, 2017 and IPR2017-01762 was terminated on September 3, 2017.
`
`Argentum therefore requests refund of the entire $14,000 institution fee. See 78 Fed.
`
`Reg. 4212, 4233 (Jan. 18, 2013) (“The entire post-institution fee would be returned
`
`to the petitioner if the Office does not institute a review.”); see also PTAB E2E
`
`Frequently Asked Questions, G10 (“If the proceeding is terminated before
`
`institution and the petition was filed on or after March 19, 2013, the petitioner may
`
`file a request for a refund of the post-institution fee paid.”).
`
`The refund may be paid by crediting the credit card used to pay the institution
`
`fee on July 12, 2017; by crediting Laurence & Phillips IP Law LLP’s deposit
`
`account no. 50-6921; by check made to Argentum Pharmaceuticals LLC and mailed
`
`to the lead attorney (Kevin Laurence, Laurence & Phillips IP Law LLP, 1940 Duke
`
`Street, Suite 200, Alexandria, VA 22314); or by any other means acceptable to the
`
`Office.
`
`Date: Oct. 10, 2017
`
`
`
`Respectfully submitted,
`
`/Kevin B. Laurence/
`
`
`
`
`
`
`
`
`
`
`Kevin B. Laurence
`Lead Counsel for Petitioner
`Registration No. 38,219
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on Oct. 4, 2017, a copy of the foregoing
`
`PETITIONER’S REQUEST FOR REFUND OF INSTITUION FEE and all
`
`documents filed with it were served via email upon the following counsel of record
`
`for the patent owner, as consented to by said counsel:
`
`Mark J. Feldstein: mark.feldstein@finnegan.com
`Joshua L. Goldberg: joshua.goldberg@finnegan.com
`Yieyie Yang: yieyie.yang@finnegan.com
`Maureen D. Queler: maureen.queler@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`
`
`
`Mark J. Stewart: stewart_mark@lilly.com
`Dan L. Wood: wood_dan_l@lilly.com
`Gerald P. Keleher: keleher_gerald@lilly.com
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`
`
`
`
`
`
`
`
`Dated: October 10, 2017
`
`
`
`
`
`Respectfully submitted,
`
`/Kevin B. Laurence/
`Kevin B. Laurence, Lead Counsel for Petitioner
`Registration No. 38,219
`klaurence@lpiplaw.com
`
`Laurence & Phillips IP Law LLP
`1940 Duke St., Ste. 200
`Alexandria, Virginia 22314
`Telephone: 703-448-8787
`
`
`
`
`
`
`
`
`